Cheapest Mounjaro UK Price - From £124.99

Our Pricing

Can I Get Mounjaro From My GP? Your Options Explained

Published on: June 03, 2026

Many UK patients ask can I get Mounjaro from my GP when exploring weight loss treatment options. While Mounjaro (tirzepatide) is licensed in the UK, NHS availability through your GP is currently extremely limited due to NICE guidance restrictions. However, private prescription pathways offer accessible alternatives for eligible patients.

Can I Get Mounjaro From My GP on the NHS?

Currently, Mounjaro is not routinely available through NHS prescriptions from your GP. NICE (National Institute for Health and Care Excellence) has not yet recommended tirzepatide for weight management within NHS England, meaning most GPs cannot prescribe it through standard NHS pathways [1]. This differs from diabetes treatment, where Mounjaro has NICE approval for type 2 diabetes management in specific circumstances.

NHS England announced in 2024 that it would not commission Mounjaro for weight loss due to budget constraints and capacity limitations within specialist weight management services [2]. Even where NICE guidance exists for diabetes, access remains restricted to secondary care specialists rather than GP surgeries in most regions.

If you're seeking Mounjaro specifically for weight management, your GP will likely advise you to explore private prescription options or refer you to specialist NHS weight management programmes that use alternative licensed treatments. Waiting times for NHS specialist services typically exceed 12-18 months in many areas.

Private Prescription Options for Mounjaro in the UK

Private prescriptions offer the primary route for UK patients to access Mounjaro for weight management. At Cured Pharmacy, Mounjaro is available from £124.99 following a clinical assessment by a UK-registered prescriber [3]. This includes your prescription, medication, and discreet home delivery.

The private prescription process involves completing a comprehensive medical questionnaire reviewed by a GMC-registered prescriber. Your clinician will assess your BMI, medical history, current medications, and weight loss goals to determine if Mounjaro is clinically appropriate. Approval typically takes under 24 hours, with next-day delivery available across the UK.

Unlike NHS pathways that require referrals and lengthy waiting lists, private online pharmacies like Cured Pharmacy provide direct access to UK prescribers specialising in weight management. All consultations are conducted by qualified healthcare professionals registered with the General Pharmaceutical Council (GPhC Registration Number 9012511), ensuring the same clinical standards as traditional GP services.

What's Included in Your Private Prescription

Your private Mounjaro prescription includes the complete KwikPen injection device pre-filled with tirzepatide, four single-use pens per box, and comprehensive administration guidance. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team provide ongoing support throughout your treatment journey, including dose titration advice and side effect management.

NHS Eligibility Criteria vs Private Prescription Requirements

If Mounjaro were available through your GP on the NHS, you would need to meet strict NICE eligibility criteria: BMI ≥35 kg/m² with at least one weight-related comorbidity, or BMI ≥30 kg/m² with specific conditions like type 2 diabetes or cardiovascular disease. You would also need documented evidence of previous weight loss attempts through behavioural interventions [2].

Private prescription pathways typically follow similar clinical safety criteria but with greater flexibility. At Cured Pharmacy, prescribers assess patients with BMI ≥30 kg/m² (or ≥27 kg/m² with weight-related conditions) who are committed to lifestyle modifications alongside medication. Your prescriber evaluates contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, and current pregnancy or breastfeeding.

The key difference lies in access rather than safety standards. Private prescribers apply the same rigorous clinical judgement as NHS doctors but without the funding restrictions and referral requirements that limit NHS availability. Both pathways require ongoing monitoring, regular follow-ups, and commitment to diet and exercise programmes.

How Mounjaro Works: The Science Behind Tirzepatide

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK for weight management [1]. Unlike single-pathway medications, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism enhances insulin secretion, reduces glucagon release, slows gastric emptying, and significantly reduces appetite through central nervous system pathways.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose of tirzepatide achieved an average 22.5% body weight reduction over 72 weeks — substantially higher than comparator treatments [1]. The SURMOUNT-3 trial demonstrated that patients maintained an average 94% of their weight loss when continuing tirzepatide after initial reduction, compared to significant regain in the placebo group [4].

The dual receptor mechanism appears to produce greater metabolic effects than GLP-1 agonists alone. Patients typically experience reduced hunger signals, increased satiety after smaller meals, and improved glycaemic control even without diabetes. Clinical trials showed 91% of participants achieved at least 5% body weight reduction, with 63% achieving ≥20% reduction on the highest dose [1].

Expected Timeline and Results

Mounjaro follows a gradual dose escalation protocol starting at 2.5mg weekly, increasing every four weeks to minimise gastrointestinal side effects. Most patients begin noticing appetite reduction within the first two weeks, with measurable weight loss typically evident by week 4-8. Maximum efficacy occurs at maintenance doses (10mg or 15mg weekly) reached after 16-20 weeks of treatment, subject to prescriber guidance and individual tolerance.

Mounjaro vs Other Weight Loss Treatments Available Privately

When your GP cannot prescribe Mounjaro through the NHS, understanding alternative treatments helps you make informed decisions. Wegovy (semaglutide) is another once-weekly injectable GLP-1 receptor agonist that demonstrated 14.9% average weight reduction in the STEP 1 trial [5]. While effective, semaglutide's single-pathway mechanism produces less weight loss than tirzepatide's dual action in head-to-head comparisons.

Saxenda (liraglutide) requires daily injections and showed 8% average weight reduction in clinical trials — lower than weekly alternatives but suitable for patients preferring smaller, more frequent doses [6]. Oral medications like Orlistat work through a different mechanism entirely, blocking approximately 30% of dietary fat absorption rather than affecting appetite hormones. Orlistat produces more modest results (5-7% weight loss) but may suit patients uncomfortable with injections.

Your choice depends on clinical factors, lifestyle preferences, and budget considerations. Injectable GLP-1 treatments require refrigeration and weekly administration, whilst oral options offer convenience without injection anxiety. All prescription weight loss medications work best alongside calorie reduction and increased physical activity — they are treatment aids, not standalone solutions.

Choosing Between Injectable and Oral Treatments

Injectable treatments like Mounjaro and Wegovy generally produce greater weight loss than oral alternatives, but they require proper injection technique and cold storage. Oral medications like Orlistat and the newly available Wegovy oral tablets offer needle-free alternatives with different side effect profiles. Your prescriber will recommend the most appropriate option based on your medical history, weight loss goals, previous treatment responses, and personal preferences regarding administration method.

How to Access Mounjaro Through Cured Pharmacy

Accessing Mounjaro privately through Cured Pharmacy takes under three minutes. Start by completing our online medical questionnaire covering your weight history, current health conditions, medications, and weight loss goals. Our UK-registered prescribers review your assessment within 24 hours, typically much faster during weekday hours.

If approved, your prescription is sent electronically to our dispensing team. We source only genuine UK-licensed Mounjaro directly from licensed wholesalers — never grey market imports. Your medication ships in 100% discreet packaging with no external pharmacy branding, delivered via tracked courier to your specified address. Most orders placed before 3pm Monday-Thursday arrive next working day.

Ongoing support is included throughout your treatment. Our clinical team, led by superintendent pharmacist Tarun Kumar (GPhC 2233073), provides guidance on injection technique, dose escalation, managing side effects, and optimising results through lifestyle modifications. You can contact our pharmacy team on (+44) 116 4646009 during business hours or through our secure patient portal for non-urgent queries.

Follow-up consultations occur every 8-12 weeks to monitor progress, adjust dosing if needed, and ensure continued safety. Your prescriber will assess weight loss trends, side effect tolerance, and overall health markers. Mounjaro is intended for long-term use — clinical trials extending beyond 72 weeks show sustained benefits with continued treatment, though individual treatment duration varies based on goals achieved and clinical response [4].

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes [TA924]. NICE. https://www.nice.org.uk/guidance/ta924 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. MHRA. https://products.mhra.gov.uk/ [accessed 13 August 2026]
4. Aronne, L. J., et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA, 331(1), 38–48. https://doi.org/10.1001/jama.2023.24945 [accessed 13 August 2026]
5. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
6. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine and is subject to prescriber approval based on individual medical suitability.